166 related articles for article (PubMed ID: 2156001)
21. Protective immunity against herpetic ocular disease in an outbred mouse model.
Metcalf JF; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
[TBL] [Abstract][Full Text] [Related]
22. Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse.
Shimeld C; Tullo AB; Hill TJ; Blyth WA; Easty DL
Arch Virol; 1985; 85(3-4):175-87. PubMed ID: 2992417
[TBL] [Abstract][Full Text] [Related]
23. The histology of the eye after zosteriform spread of herpes simplex virus in the mouse.
Claoue C; Hodges T; Hill T; Blyth W; Easty D
Br J Exp Pathol; 1987 Aug; 68(4):585-93. PubMed ID: 2820460
[TBL] [Abstract][Full Text] [Related]
24. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
Shimizu F; Monma Y; Sekizawa T; Kamiyama K
J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
[TBL] [Abstract][Full Text] [Related]
25. Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation.
Sekizawa T; Openshaw H; Wohlenberg C; Notkins AL
Science; 1980 Nov; 210(4473):1026-8. PubMed ID: 6254149
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.
Laycock KA; Lee SF; Brady RH; Pepose JS
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2741-6. PubMed ID: 1654309
[TBL] [Abstract][Full Text] [Related]
27. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
Metcalf JF; Chatterjee S; Koga J; Whitley RJ
Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
[TBL] [Abstract][Full Text] [Related]
28. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease.
Metcalf JF; Koga J; Chatterjee S; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):173-7. PubMed ID: 3030642
[TBL] [Abstract][Full Text] [Related]
29. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
Nesburn AB; Ghiasi H; Wechsler SL
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1497-502. PubMed ID: 2167298
[TBL] [Abstract][Full Text] [Related]
30. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD; Pereira L; Baringer JR
Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
[TBL] [Abstract][Full Text] [Related]
31. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
Harney BA; Easty DL; Skinner GR
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea.
Hill JM; Kwon BS; Shimomura Y; Colborn GL; Yaghmai F; Gangarosa LP
Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):243-7. PubMed ID: 6298139
[TBL] [Abstract][Full Text] [Related]
33. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.
Rajcáni J; Kutinová L; Vonka V
Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035
[TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):411-8. PubMed ID: 2318582
[TBL] [Abstract][Full Text] [Related]
35. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.
Abghari SZ; Stulting RD
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265
[TBL] [Abstract][Full Text] [Related]
36. Does herpes simplex virus establish latency in the eye of the mouse?
Claoué CM; Blyth WA; Hill TJ; Easty DL
Eye (Lond); 1987; 1 ( Pt 4)():525-8. PubMed ID: 2450791
[TBL] [Abstract][Full Text] [Related]
37. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
38. Targets of herpes simplex virus type 1 infection in a mouse corneal model.
Martin JR; Jenkins FJ; Henken DB
Acta Neuropathol; 1991; 82(5):353-63. PubMed ID: 1662854
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical identification of trigeminal ganglion neurons that innervate the mouse cornea: relevance to intercellular spread of herpes simplex virus.
LaVail JH; Johnson WE; Spencer LC
J Comp Neurol; 1993 Jan; 327(1):133-40. PubMed ID: 7679419
[TBL] [Abstract][Full Text] [Related]
40. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
Hendricks RL; Janowicz M; Tumpey TM
J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
